TREM-1 Receptor: A Promising Therapeutic Target for Inflammatory Diseases
The Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) is emerging as a critical amplifier of the human innate immune system, according to a review published in Current Molecular Pharmacology. Researchers from Cairo University and E-JUST University identify this receptor as a potential therapeutic target for inflammatory conditions ranging from sepsis to Alzheimer’s disease, though clinical … Read more